Tibet Pharmaceuticals' updated online Investor Fact Sheet is now available in China

Apr 18 2011

Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, announces the availability of an updated online Investor Fact Sheet.

"As part of our mission to keep investors informed with the latest developments at the company, we are pleased to release our updated fact sheet," said Taylor Guo, Chief Executive Officer at Tibet Pharmaceuticals. "As demonstrated by our recently announced fully-audited financial results, fiscal 2010 was a tremendous year for our company, having grown revenue 41% to $32.4 million and net income 42% to $13.1 million, compared to fiscal 2009.  In light of Tibet Pharmaceuticals' solid results, the traditional Tibetan medicine market represents an extremely fragmented business, with no clear leaders and plenty of room for growth through consolidation. This presents a tremendous opportunity for Tibet Pharmaceuticals and we plan to take advantage of this through potential accretive acquisitions in 2011."

"We look forward to increasing communication with the investor community over the next several weeks and on a more proactive basis going forward," continued Mr. Guo.  "We remain committed to the highest levels of compliance in the US capital markets and we intend to provide updates on our business opportunities and future growth initiatives as we strive to improve our revenues, earnings and, ultimately, create long term value for our shareholders."

The Investor Fact Sheet provides a clear overview of Tibet Pharmaceuticals' business model and growth potential in China's traditional Tibetan medicine market, and is a great resource for both existing shareholders and prospective investors alike.